Riskpilot← Back to searchSign inGet full accessMedioxygen Oy
OYDissolvedY-tunnus 1516312-8Kissankellontie 8Medical specialists activities · NACE 8622Est. 1999— employeeswww.medioxygen.fi
Revenue 2025
EUR -1K
EBITDA margin
321.2%
-459% vs 2024
Equity ratio
3.6%
Financial strength
Net profit 2025
EUR -5K
-472% vs 2024
| Revenue | EUR -1K | — |
| EBITDA | EUR -3K | -459% |
| Net profit | EUR -5K | -472% |
| Total assets | EUR 59K | +709% |
| Equity | EUR 2K | -70% |
| Employees | — | — |
Legal name
Medioxygen Oy
Y-tunnus number
1516312-8
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
5. helmikuuta 1999
Share capital
EUR 8 409
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on ylipainehappihoitoon erikoistuneen sairaanhoito- ja tutkimuslaitoksen ylläpito, ylipainehappihoidon ja muiden sairauden- ja terveydenhoito- sekä laboratoriopalveluiden antaminen, ylipainehappihoitoon liittyvien tutkimusten suorittaminen ja tutkimuskonsultointi. Yhtiö voi hallita ja omistaa osakkeita ja kiinteistöjä.
Address
Kissankellontie 8
Website
www.medioxygen.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 | 0 | — | — | −1 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 3 | −1 | 1 | 1 | −3 |
| Depreciation & amort. | — | — | — | — | −2 |
| EBIT | 3 | −1 | −1 | −1 | −5 |
| Net financials | — | — | — | — | — |
| Profit before tax | 3 | −1 | −1 | −1 | −5 |
| Tax | −0 | −0 | — | — | — |
| Net profit | 3 | −1 | −1 | −1 | −5 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 60 | 59 | 58 | 7 | 59 |
| Equity | 60 | 59 | 58 | 7 | 2 |
| Long-term debt | — | — | — | — | — |
| Short-term debt | 0 | 0 | — | — | 57 |
| Total debt | 0 | 0 | — | — | 57 |
EBITDA margin
-322500.0%
This company
15.8%
Market median
-2041239% vs market
20212025
Equity ratio
3.6%
This company
38.2%
Market median
-91% vs market
20212025
Return on equity
-238.8%
This company
18.4%
Market median
-1398% vs market
20212025
Net profit margin
-517300.0%
This company
8.1%
Market median
-6386520% vs market
20212025
Asset turnover
-0.02×
This company
1.12×
Market median
-102% vs market
20212025
Debt / equity
26.41×
This company
0.62×
Market median
-4160% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
ES Confidential Clerk | Confidential Clerk | 2025 |
KM Chief Executive Officer | Chief Executive Officer | 2022 |
LF Deputy Member | Deputy Member | 2019 |
| Former (3) | ||
PS Deputy auditor | Deputy auditor | 2011 – 2025 |
JV Chief Executive Officer | Chief Executive Officer | 2004 – 2022 |
KA | Audit | 2011 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Board of Directors | 2011 – 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medioxygen Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per-Olof Söderlund | Deputy auditor | 0 companies |
| Esa Sakari Romppanen | Confidential Clerk | 0 companies |
| Kustaa Mauri Numminen | Chief Executive Officer | 0 companies |
| Jari Veli Juhani Suvilehto | Chief Executive Officer | 0 companies |
| Leo Feodor Moring | Deputy Member | 0 companies |
| Kare Aukusti Kauppinen | Audit | 0 companies |
| Juha Tapani Kuokkanen | Board of Directors | 0 companies |